Evolve: The Latest GPU Benchmark Suite

Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ -- Traverse Research, one of the leading companies in graphics research and development, today announced the global launch

Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

SHANGHAI, March 24, 2025 /PRNewswire/ -- 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Exhibition " alt="Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application

Strider Named to Fast Company's 2025 List of Most Innovative Companies

Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intelligence, has been named to Fast Company's prestigious

Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announce the listing of Asia's first batch of 9 single stock L&I

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation of SCB-1019 as part of a respiratory

Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a

CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS

AUCKLAND, New Zealand, March 24, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in safety, security and risk-based engineering and consulting, today announced that its partner firm, Crossfire, has officially rebranded to Jensen Hughes. This